首页> 美国政府科技报告 >Morbidity and Mortality Weekly Report, June 14, 2002, Volume 51, Number RR-8. Guidelines for Preventing Opportunistic Infections Among HIV-Infected Persons - 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
【24h】

Morbidity and Mortality Weekly Report, June 14, 2002, Volume 51, Number RR-8. Guidelines for Preventing Opportunistic Infections Among HIV-Infected Persons - 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

机译:发病率和死亡率周报,2002年6月14日,第51卷,RR-8号。预防艾滋病病毒感染者机会性感染的指南 - 2002年。美国公共卫生服务和美国传染病学会的建议。

获取原文

摘要

In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelines for preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV); these guidelines were updated in 1997 and 1999. This fourth edition of the guidelines, made available on the Internet in 2001, is intended for clinicians and other health-care providers who care for HIV-infected persons. The goal of these guidelines is to provide evidence-based guidelines for preventing OIs among HIV-infected adults and adolescents, including pregnant women, and HIV-exposed or infected children. Nineteen OIs, or groups of OIs, are addressed, and recommendations are included for preventing exposure to opportunistic pathogens, preventing first episodes of disease by chemkprophylaxis or vaccination (primary prophylaxis), and preventing disease recurrence (secondary prophylaxis). Major changes since the last edition of he guidelines include (1) updated recommendations for discontinuing primary and secondary OI prophylaxis among persons whose CD4' T lymphocyte counts have increased in response to antiretroviral therapy; (2) emphasis on screening all HIV-infected persons for infection with hepatitis C virus; (3) new information regarding transmission of human herpesvirus 8 infection; (4) new information regarding drug interactions, chiefly related to rifamycins and antirectoviral drugs; and (5) revised recommendations for immunizing HIV-infected adults and adolescents and HIV-exposed or infected children.

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号